Abstract
Objectives:
The aim of this study was to determine if the actions of progesterone on preterm labor are accomplished through modulation of the percentage of regulatory T-cells (Treg).
Methods:
The study was a cohort pilot study made in a single center tertiary obstetrical unit with women in preterm labor arrested with tocolytic treatment. Variation of the number and percentage of Treg cells obtained from peripheral blood samples of women with preterm labor were calculated by flow cytometry, before and after progesterone administration.
Results:
In the paired samples for each patient, there was a significant difference in the Treg cell pool after progesterone treatment, with an increase in both their percentage (48.9 vs. 53; P=0.07) and absolute number (14.8 vs. 56.5 cells/μL; P=0.046).
Conclusions:
This research demonstrated a considerable increase in the Treg cell pool after progesterone treatment. This indicates a possible mechanism for progesterone treatment benefits in preterm labor, potentially increasing its more rational use.
Acknowledgments
This research received supporting funding from the Office of Research Support, Faculty of Medicine, University of Coimbra, Portugal.
References
[1] Schober L, Radnai D, Schmitt E, Mahnke K, Sohn C, Steinborn A. Term and preterm labor: decreased suppressive activity and changes in composition of the regulatory T-cell pool. Immunol Cell Biol. 2012;90:935–44.10.1038/icb.2012.33Search in Google Scholar PubMed
[2] Byrns MC. Regulation of progesterone signaling during pregnancy: implications for the use of progestins for the prevention of preterm birth. J Steroid Biochem Mol Biol. 2014;139:173–81.10.1016/j.jsbmb.2013.01.015Search in Google Scholar PubMed
[3] Zachariades E, Mparmpakas D, Pang Y, Rand-Weaver M, Thomas P, Karteris E. Changes in placental progesterone receptors in term and preterm labour. Placenta. 2012;33:367–72.10.1016/j.placenta.2012.01.002Search in Google Scholar PubMed
[4] Thaxton JE, Nevers TA, Sharma S. TLR-mediated preterm birth in response to pathogenic agents. Infect Dis Obstet Gynecol. 2010;2010.10.1155/2010/378472Search in Google Scholar PubMed PubMed Central
[5] Polese B, Gridelet V, Araklioti E, Martens H, Perrier d’Hauterive S, Geenen V. The endocrine milieu and CD4 T-lymphocyte polarization during pregnancy. Front Endicrinol. 2014;5:106.10.3389/fendo.2014.00106Search in Google Scholar PubMed PubMed Central
[6] Leber A, Teles A, Zenclussen AC. Regulatory T cells and their role in pregnancy. Am J Reprod Immunol. 2010;63:445–59.10.1111/j.1600-0897.2010.00821.xSearch in Google Scholar PubMed
[7] Lastovicka J. The phenotypic markers of CD4+CD25+ T regulatory lymphocytes. Res Immunol. 2013;2013:1–14.10.5171/2013.119348Search in Google Scholar
[8] Kisielewicz A, Schaier M, Schmitt E, Hug F, Haensch GM, Meuer S, et al. A distinct subset of HLA-DR+-regulatory T cells is involved in the induction of preterm labor during pregnancy and in the induction of organ rejection after transplantation. Clin Immunol. 2010;137:209–20.10.1016/j.clim.2010.07.008Search in Google Scholar PubMed
[9] Xiong H, Zhou C, Qi G. Proportional changes of CD4+CD25+Foxp3+ regulatory T cells in maternal peripheral blood during pregnancy and labor at term and preterm. Clin Invest Med. 2010;33:E422.10.25011/cim.v33i6.14594Search in Google Scholar PubMed
[10] Dressing GE, Goldberg JE, Charles NJ, Schwertfeger KL, Lange CA. Membrane progesterone receptor expression in mammalian tissues: a review of regulation and physiological implications. Steroids. 2011;76:11–17.10.1016/j.steroids.2010.09.006Search in Google Scholar PubMed PubMed Central
[11] Lee JH, Lydon JP, Kim CH. Progesterone suppresses the mTOR pathway and promotes generation of induced regulatory T cells with increased stability. Eur J Immunol. 2012;42:2683–96.10.1002/eji.201142317Search in Google Scholar PubMed PubMed Central
[12] Mao G, Wang J, Kang Y, Tai P, Wen J, Zou Q, et al. Progesterone increases systemic and local uterine proportions of CD4+CD25+ Treg cells during midterm pregnancy in mice. Endocrinology. 2010;151:5477–88.10.1210/en.2010-0426Search in Google Scholar PubMed
[13] da Fonseca EB, Bittar RE, Carvalho MH, Zugaib M. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study. Am J Obstet Gynecol. 2003;188:419–24.10.1067/mob.2003.41Search in Google Scholar PubMed
[14] Dodd JM, Flenady VJ, Cincotta R, Crowther CA. Progesterone for the prevention of preterm birth: a systematic review. Obstet Gynecol. 2008;112:127–34.10.1097/AOG.0b013e31817d0262Search in Google Scholar PubMed
[15] Fonseca EB, Celik E, Parra M, Singh M, Nicolaides KH. Progesterone and the risk of preterm birth among women with a short cervix. N Engl J Med. 2007;357:462–9.10.1056/NEJMoa067815Search in Google Scholar PubMed
[16] O’Brien JM, Adair CD, Lewis DF, Hall DR, Defranco EA, Fusey S, et al. Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol. 2007;30:687–96.10.1002/uog.5158Search in Google Scholar PubMed
[17] Dodd JM, Crowther CA, Cincotta R, Flenady V, Robinson JS. Progesterone supplementation for preventing preterm birth: a systematic review and meta-analysis. Acta Obstet Gynecol Scand. 2005;84:526–33.10.1111/j.0001-6349.2005.00835.xSearch in Google Scholar PubMed
[18] Dodd JM, Flenady V, Cincotta R, Crowther CA. Prenatal administration of progesterone for preventing preterm birth. Cochrane Database Syst Rev. 2006;1:CD004947.10.1002/14651858.CD004947.pub2Search in Google Scholar PubMed
[19] Facchinetti F, Paganelli S, Comitini G, Dante G, Volpe A. Cervical length changes during preterm cervical ripening: effects of 17-alpha-hydroxyprogesterone caproate. Am J Obstet Gynecol. 2007;19:453.e451–4;discussion 421.10.1016/j.ajog.2006.09.009Search in Google Scholar PubMed
[20] Mackenzie R, Walker M, Armson A, Hannah ME. Progesterone for the prevention of preterm birth among women at increased risk: a systematic review and meta-analysis of randomized controlled trials. Am J Obstet Gynecol. 2006;194:1234–42.10.1016/j.ajog.2005.06.049Search in Google Scholar PubMed
[21] Meis PJ, Klebanoff M, Thom E, Dombrowski MP, Sibai B, Moawad AH, et al. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med. 2003;348:2379–85.10.1056/NEJMoa035140Search in Google Scholar
[22] Rouse DJ, Caritis SN, Peaceman AM, Sciscione A, Thom EA, Spong CY, et al. A trial of 17 alpha-hydroxyprogesterone caproate to prevent prematurity in twins. N Engl J Med. 2007;357:454–61.10.1056/NEJMoa070641Search in Google Scholar
[23] Sanchez-Ramos L, Kaunitz AM, Delke I. Progestational agents to prevent preterm birth: a meta-analysis of randomized controlled trials. Obstet Gynecol. 2005;105:273–9.10.1097/01.AOG.0000150559.59531.b2Search in Google Scholar
[24] Erny R, Pigne A, Prouvost C, Gamerre M, Malet C, Serment H, et al. The effects of oral administration of progesterone for premature labor. Am J Obstet Gynecol. 1986;154:525–9.10.1016/0002-9378(86)90595-8Search in Google Scholar
[25] Borna S, Sahabi N. Progesterone for maintenance tocolytic therapy after threatened preterm labour: a randomised controlled trial. Aust NZ J Obstet Gynaecol. 2008;48:58–63.10.1111/j.1479-828X.2007.00803.xSearch in Google Scholar PubMed
[26] Areia A, Fonseca E, Moura P. Progesterone use after successful treatment of threatened pre-term delivery. J Obstet Gynaecol. 2013;33:678–81.10.3109/01443615.2013.820266Search in Google Scholar PubMed
[27] Creasy RK, Resnik R, Iams JD, Lockwood CJ, Greene MF, Moore T. Creasy and Resnik’s maternal-fetal medicine: principles and practice. Elsevier Health Sciences; 2013.Search in Google Scholar
[28] Rai P, Rajaram S, Goel N, Ayalur Gopalakrishnan R, Agarwal R, Mehta S. Oral micronized progesterone for prevention of preterm birth. Int J Gynaecol Obstet. 2009;104:40–3.10.1016/j.ijgo.2008.08.029Search in Google Scholar PubMed
[29] Koucky M, Malickova K, Cindrova-Davies T, Germanova A, Parizek A, Kalousova M, et al. Low levels of circulating T-regulatory lymphocytes and short cervical length are associated with preterm labor. J Reprod Immunol. 2014;106:110–7.10.1016/j.jri.2014.04.001Search in Google Scholar PubMed
[30] Holst D, Garnier Y. Preterm birth and inflammation-The role of genetic polymorphisms. Eur J Obstet Gynecol Reprod Biol. 2008;141:3–9.10.1016/j.ejogrb.2008.07.020Search in Google Scholar PubMed
[31] Norwitz ER, Caughey AB. Progesterone supplementation and the prevention of preterm birth. Rev Obstet Gynecol. 2011;4:60–72.Search in Google Scholar
The authors stated that there are no conflicts of interest regarding the publication of this article.
©2016 Walter de Gruyter GmbH, Berlin/Boston
